Researchers looked at pricing data for 79 brand-name drugs between 2015-2020 to assess the validity of drugmakers’ claims that wholesale drug prices do not accurately reflect the out-of-pocket costs patients will pay.
They found that the drugs’ list prices increased by nearly 17 percent, and patients’ out-of-pocket spending increased by about 3.5 percent.
The increases in out-of-pocket cost varied by patients’ insurance type. Patients who had fixed copayments (about half of insured Americans) were mostly unaffected by drug price increases, but out-of-pocket costs for patients with deductibles and coinsurance (the other half of insured Americans) increased by 15 percent.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
